Glenmark Pharmaceuticals Fundamental Analysis
GLENMARK
23313.70 (-0.16%)
Last updated on 1 Oct, 2026 | 15:55 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
36.67
P/B Ratio
6.01
Div. Yield
0.11
Sector P/E
42.73
Sector P/B
3.57
Sec. Div. Yield
0.51
Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 36.67, compared to the sector average of 42.73. Its P/B Ratio stands at 6.01, while the sector’s is 3.57. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 0.51%.
Glenmark Pharmaceuticals Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Average
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals
Share Price - Glenmark Pharmaceuticals
Share Price chart - Glenmark Pharmaceuticals
Technical Analysis - Glenmark Pharmaceuticals
Peer Comparison - Glenmark Pharmaceuticals
Share Price History - Glenmark Pharmaceuticals
Dividend - Glenmark Pharmaceuticals
Board of Directors - Glenmark Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLENMARK
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC